Valute / OTLK
OTLK: Outlook Therapeutics Inc
0.85
USD
0.24
(22.02%)
Il tasso di cambio OTLK ha avuto una variazione del -22.02% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 0.84 e ad un massimo di 1.07.
Segui le dinamiche di Outlook Therapeutics Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
OTLK News
- OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug
- Outlook Therapeutics stock rating downgraded by H.C. Wainwright on FDA rejection
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16%
- Nasdaq Surges 100 Points; Dollar General Earnings Beat Views - CaliberCos (NASDAQ:CWD), Accelerant Holdings (NYSE:ARX)
- FDA Rejects Outlook Therapeutics Eye Drug For Second Time - Outlook Therapeutics (NASDAQ:OTLK)
- US Stocks Mixed; Nvidia Posts Upbeat Earnings - CaliberCos (NASDAQ:CWD), AquaBounty Techs (NASDAQ:AQB)
- US FDA declines to approve Outlook Therapeutics’ drug for eye condition
- Outlook Therapeutics stock falls after FDA rejects wet AMD drug
- Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Beneficient (NASDAQ:BENF), Bollinger Innovations (NASDAQ:BINI)
- Why The Odds Point To A Favorable FDA Decision For Outlook (NASDAQ:OTLK)
- Outlook Therapeutics Reports Q3 Revenue
- Oncobiologics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates
- New Strong Buy Stocks for July 30th
- Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event
- Brookline Capital lowers Outlook Therapeutics stock price target on cash balance
- Rubrik To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday - Broadcom (NASDAQ:AVGO), Aemetis (NASDAQ:AMTX)
- Ascendiant Capital lowers Outlook Therapeutics stock price target to $21
- Outlook Therapeutics launches LYTENAVA in Germany and UK
- Outlook Therapeutics ® Announces Pricing of $13.0 Million Public Offering
- Outlook Therapeutics announces public stock offering
- Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
- Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday - Alnylam Pharmaceuticals (NASDAQ:ALNY), Bath & Body Works (NYSE:BBWI)
Intervallo Giornaliero
0.84
1.07
Intervallo Annuale
0.79
8.31
- Chiusura Precedente
- 1.09
- Apertura
- 1.04
- Bid
- 0.85
- Ask
- 1.15
- Minimo
- 0.84
- Massimo
- 1.07
- Volume
- 13.311 K
- Variazione giornaliera
- -22.02%
- Variazione Mensile
- -56.41%
- Variazione Semestrale
- -45.51%
- Variazione Annuale
- -88.48%
31 agosto, domenica